questionText: To ask the Secretary of State for Health and Social Care, whether he plans to introduce a national plan to tackle shortages of pancreatic enzyme replacement therapy.
answerText: The Department has been working with suppliers to address current supply issues with Creon, which is a brand of pancreatic enzyme replacement therapy (PERT) used by patients with conditions such as cystic fibrosis and certain cancers including pancreatic ...
heading: Pancreatic Enzyme Replacement Therapy: Shortages